Perceval S Aortic Heart Valve Study- North America

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 355 participants.

Also called NCT01810679

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 355 participants (enrolled count) (from the registry)
Sponsor
Sorin Group USA, Inc. (from the registry)
Registry
  • NCT NCT01810679
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01810679. Allocation not applicable; no masking; primary purpose treatment. Start 2013-04 (registry gives no type); primary completion 2016-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Perceval S Aortic Heart Valve Study- North America
Condition
Aortic Valve Stenosis
Condition
Aortic Valve Stenosis With Insufficiency
Condition
Regurgitation, Aortic Valve
Condition
Aortic Valve Incompetence
Intervention (Device)
Perceval S Aortic Heart Valve
Lead sponsor
Sorin Group USA, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01810679
Content hash
7955ab155da7ff66b78062bfcae02bebf5a7746015e97b00d8d5a10ce031ed8f